Merck (MRK) Other Non-Current Liabilities (2009 - 2026)

Merck (MRK) has reported Other Non-Current Liabilities for 17 consecutive years, with $7.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 7.71% year-over-year to $7.6 billion in Q2 2026; TTM through Jun 2026 was $7.6 billion, a 7.71% increase from a year earlier, with the FY2025 full-year figure at $7.7 billion, up 18.92% from the prior year.
• Other Non-Current Liabilities was $7.6 billion for Q2 2026 at Merck, down from $7.6 billion in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $9.7 billion in Q1 2022 and troughed at $208.0 million in Q3 2024.
• A 5-year average of $4.4 billion and a median of $6.6 billion in 2024 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities sank 97.17% in 2024 and soared 3583.17% in 2025, its largest moves.
• Over 5 years, Other Non-Current Liabilities stood at $8.3 billion in 2022, then sank by 95.75% to $354.0 million in 2023, then jumped by 1726.27% to $6.5 billion in 2024, then grew by 18.92% to $7.7 billion in 2025, then dropped by 1.5% to $7.6 billion in 2026.
• The last three Other Non-Current Liabilities figures came in at $7.6 billion (Q2 2026), $7.6 billion (Q1 2026), and $7.7 billion (Q4 2025), per Business Quant data.